Home › Pericardial Disorders › New York › New York City
Pericardial Disorders clinical trials in New York City, NY
4 studies for Pericardial Disorders are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Transition to KPL-387 Monotherapy Dosing & Administration Study
RecruitingPhase 2
- Investigational Site 011, New York
- Investigational Site 003, New York
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
RecruitingPhase 2
- Columbia University Irving Medical Center, New York
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
RecruitingPhase 3
- NYU Langone Health, New York
- Columbia University - New York Presbyterian, New York
- Lenox Hill Hospital, New York
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
RecruitingPhase 2/3
- Investigational Site 015, New York
- Investigational Site 022, New York
About Pericardial Disorders
The pericardium is a membrane that surrounds the heart. Pericardial disorders include pericarditis, pericardial effusion, and cardiac tamponade.
More about Pericardial Disorders on MedlinePlus
Pericardial Disorders trials in other cities
- Cleveland, OH4 studies
- Rochester, MN4 studies
- Houston, TX4 studies
- Richmond, VA4 studies
- Chicago, IL4 studies
- Boston, MA4 studies
- Burlington, VT3 studies
- Los Angeles, CA3 studies
- Charlottesville, VA3 studies
- Phoenix, AZ3 studies
- Baltimore, MD3 studies
- Santa Monica, CA3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.